Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

UV light helped human hair transplants survive in mice without broad immunosuppression.

No medications for alcohol dependence have been approved for marketing yet.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

The method effectively detects banned substances in urine for sports antidoping.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

The new compound may be a safer alternative to finasteride for prostate protection.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Some medications can cause acne, and stopping these drugs is the main treatment.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Both steroid treatments effectively regrow hair in severe alopecia areata.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Upadacitinib may effectively treat resistant lichen planopilaris.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Belatacept may be a promising treatment for alopecia areata.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.